Swedish Orphan Biovitrum AB (publ) (BIOVF)
Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
At close: 01:26PM EDT
| Previous Close | 22.87 |
| Open | 23.74 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's Range | 22.87 - 22.87 |
| 52 Week Range | 18.35 - 27.79 |
| Volume | |
| Avg. Volume | 87 |
| Market Cap | 8.17B |
| Beta (5Y Monthly) | 0.26 |
| PE Ratio (TTM) | 33.63 |
| EPS (TTM) | 0.68 |
| Earnings Date | N/A |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | N/A |
PR NewswireNotice of Annual General Meeting in Swedish Orphan Biovitrum AB (publ)
The shareholders in Swedish Orphan Biovitrum AB (publ) (Sobi®) Reg. No. 556038-9321, are hereby summoned to the Annual General Meeting (the "Meeting"), to be held on Tuesday, 14 May 2024 at 15.00 at IVA Konferenscenter, Grev Turegatan 16, Stockholm, Sweden.
PR NewswireSobi publishes Annual and sustainability report for 2023
Swedish Orphan Biovitrum AB (publ) (Sobi®) today published its Annual and sustainability report for 2023. Inspired by caring and powered by science, the integrated report summarises business and strategy, financial performance, and work on sustainability.
PR NewswireSobi publishes Q4 2023 report: Strong revenue performance and growth into 2024
Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the fourth quarter 2023.
© 2024 Yahoo. All rights reserved.